TBD-UK: The UK response in the discovery and development of new TB drugs. Dr Geoff Coxon Deputy Leader & Director of Medicinal Chemistry, TBD-UK APPG-TB.
Financing and Coordination of R&D for neglected diseases: Challenges and opportunities Consultative Expert Working Group on Research and Development Open.
GLOBAL DRUG FACILITY Improving country access to anti-TB medicines Andrea de Lucia, GDF Team Leader 1 st line Country Support WHO/UNICEF Technical Briefing.
GSK’s Commitment to Malaria Didier Lapierre Vice President, Head of Global Clinical Development Centre for Early Development and DDW Vaccines All Party.
Johannesburg, 13 th August 2009 Outstanding Business Action to Stop TB: How Companies Contribute to the Global Fight 2009 TB Case Studies Shuma Panse Global.
October 31, 2014 Satellite Symposium: The pediatric TB drug market: progress and future direction Market understanding: new data on the purchasing habits.
GLOBAL DRUG FACILITY Improving country access to anti-TB medicines
July 21, 2014 20 th International AIDS Conference
With support from the TB Alliance
Clinical Study NC-001 Stephen Murray, MD, PhD Global Alliance for TB Drug Development
Unified Drug Sensitive/Drug Resistant Development Pathway for Novel TB Drug Regimens
TBD-UK: The UK response in the discovery and development of new TB drugs.
